CCN1 and chronic kidney disease: Mechanistically, inactivation of the MAPK signaling pathway was observed under specific CCN1 deficiency or inhibition in both heart tissues and H9c2 cells cultured with serum from CKD mice, while MAPK-related agonist could partially reverse the cardioprotective effect caused by CCN1 inhibition.